Detalhe da pesquisa
1.
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
Oncology
; 102(3): 239-251, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37729889
2.
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Hepatol Res
; 2024 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38539054
3.
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
Oncology
; 101(8): 491-501, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37429266
4.
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
BMC Gastroenterol
; 23(1): 222, 2023 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37380950
5.
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
J Gastroenterol Hepatol
; 38(9): 1637-1646, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37475200
6.
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Int J Cancer
; 151(12): 2278-2290, 2022 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36054900
7.
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.
BMC Gastroenterol
; 22(1): 275, 2022 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35655156
8.
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
BMC Gastroenterol
; 22(1): 535, 2022 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36550416
9.
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
J Gastroenterol Hepatol
; 37(3): 592-599, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34928509
10.
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
Oncology
; 99(5): 327-335, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33677453
11.
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Oncology
; 99(8): 507-517, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33946070
12.
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
Oncology
; 99(8): 491-498, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34000725
13.
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
BMC Gastroenterol
; 21(1): 306, 2021 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34332532
14.
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
J Gastroenterol Hepatol
; 36(6): 1685-1693, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33326154
15.
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors.
Oncology
; 98(10): 727-733, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32712613
16.
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
Oncology
; 98(11): 787-797, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32882687
17.
Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
Hepatol Res
; 50(7): 885-888, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32088930
18.
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
J Gastroenterol Hepatol
; 35(8): 1412-1419, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31896166
19.
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
Oncology
; 97(2): 75-81, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31242488
20.
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Oncology
; 94(4): 215-222, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29428943